JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M307095200 on October 7, 2003

J. Biol. Chem., Vol. 278, Issue 51, 51630-51637, December 19, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/51/51630    most recent
M307095200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfeiffer, M.
Right arrow Articles by Schulz, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfeiffer, M.
Right arrow Articles by Schulz, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Heterodimerization of Substance P and µ-Opioid Receptors Regulates Receptor Trafficking and Resensitization*

Manuela Pfeiffer{ddagger}, Susanne Kirscht{ddagger}, Ralf Stumm, Thomas Koch, Daifei Wu, Magdalena Laugsch, Helmut Schröder, Volker Höllt, and Stefan Schulz§

From the Department of Pharmacology and Toxicology, Otto-von-Guericke University, 39120 Magdeburg, Germany

The µ-opioid receptor (MOR1) and the substance P receptor (NK1) coexist and functionally interact in nociceptive brain regions; however, a molecular basis for this interaction has not been established. Using coimmunoprecipitation and bioluminescence resonance energy transfer (BRET), we show that MOR1 and NK1 can form heterodimers in HEK 293 cells coexpressing the two receptors. Although NK1-MOR1 heterodimerization did not substantially change the ligand binding and signaling properties of these receptors, it dramatically altered their internalization and resensitization profile. Exposure of the NK1-MOR1 heterodimer to the MOR1-selective ligand [D-Ala2,Me-Phe4,Gly5-ol]enkephalin (DAMGO) promoted cross-phosphorylation and cointernalization of the NK1 receptor. Conversely, exposure of the NK1-MOR1 heterodimer to the NK1-selective ligand substance P (SP) promoted cross-phosphorylation and cointernalization of the MOR1 receptor. In cells expressing MOR1 alone, {beta}-arrestin directs the receptors to clathrin-coated pits, but does not internalize with the receptor. In cells expressing NK1 alone, {beta}-arrestin internalizes with the receptor into endosomes. Interestingly, in cells coexpressing MOR1 and NK1 both DAMGO and SP induced the recruitment of {beta}-arrestin to the plasma membrane and cointernalization of NK1-MOR1 heterodimers with {beta}-arrestin into the same endosomal compartment. Consequently, resensitization of MOR1-dependent receptor functions was severely delayed in coexpressing cells as compared with cells expressing MOR1 alone. Together, our findings indicate that MOR1 by virtue of its physical interaction with NK1 is sequestered via an endocytotic pathway with delayed recycling and resensitization kinetics.


Received for publication, July 3, 2003 , and in revised form, September 22, 2003.

* This work was supported by Deutsche Forschungsgemeinschaft Grant SCHU 924/4-3 (to S. S.) and by Bundesministerium für Bildung und Forschung Grant NBL3 (to M. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Both authors contributed equally to this work.

§ To whom correspondence should be addressed: Dept. of Pharmacology and Toxicology, Otto-von-Guericke University, 39120 Magdeburg, Leipziger Strasse 44, Germany. Tel.: 49-391-671-5881; Fax: 49-391-671-5869; E-mail: Stefan.Schulz{at}Medizin.Uni-Magdeburg.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
A. Kolodziej, S. Schulz, A. Guyon, D.-F. Wu, M. Pfeiffer, V. Odemis, V. Hollt, and R. Stumm
Tonic Activation of CXC Chemokine Receptor 4 in Immature Granule Cells Supports Neurogenesis in the Adult Dentate Gyrus
J. Neurosci., April 23, 2008; 28(17): 4488 - 4500.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-F. Wu, T. Koch, Y.-J. Liang, R. Stumm, S. Schulz, H. Schroder, and V. Hollt
Membrane Glycoprotein M6a Interacts with the {micro}-Opioid Receptor and Facilitates Receptor Endocytosis and Recycling
J. Biol. Chem., July 27, 2007; 282(30): 22239 - 22247.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
A. Hammers, M.-C. Asselin, R. Hinz, I. Kitchen, D. J. Brooks, J. S. Duncan, and M. J. Koepp
Upregulation of opioid receptor binding following spontaneous epileptic seizures
Brain, April 1, 2007; 130(4): 1009 - 1016.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Roumy, C. Lorenzo, S. Mazeres, S. Bouchet, J.-M. Zajac, and C. Mollereau
Physical Association between Neuropeptide FF and {micro}-Opioid Receptors as a Possible Molecular Basis for Anti-opioid Activity
J. Biol. Chem., March 16, 2007; 282(11): 8332 - 8342.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y.-J. Liang, D.-F. Wu, L.-Q. Yang, V. Hollt, and T. Koch
Interaction of the {micro}-Opioid Receptor with Synaptophysin Influences Receptor Trafficking and Signaling
Mol. Pharmacol., January 1, 2007; 71(1): 123 - 131.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Z. Chen, P. A. Deddish, R. D. Minshall, R. P. Becker, E. G. Erdos, and F. Tan
Human ACE and bradykinin B2 receptors form a complex at the plasma membrane
FASEB J, November 1, 2006; 20(13): 2261 - 2270.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. A. Snook, G. Milligan, B. L. Kieffer, and D. Massotte
{micro}-{delta} Opioid Receptor Functional Interaction: Insight Using Receptor-G Protein Fusions
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. H. Meyer, J.-M. Segura, K. L. Martinez, R. Hovius, N. George, K. Johnsson, and H. Vogel
FRET imaging reveals that functional neurokinin-1 receptors are monomeric and reside in membrane microdomains of live cells
PNAS, February 14, 2006; 103(7): 2138 - 2143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Huttenrauch, B. Pollok-Kopp, and M. Oppermann
G Protein-coupled Receptor Kinases Promote Phosphorylation and {beta}-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers
J. Biol. Chem., November 11, 2005; 280(45): 37503 - 37515.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. C. Prinster, C. Hague, and R. A. Hall
Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance
Pharmacol. Rev., September 1, 2005; 57(3): 289 - 298.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Milligan
G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology
Mol. Pharmacol., July 1, 2004; 66(1): 1 - 7.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.